AMNEAL PHARMACEUTICALS, INC EBITDA Margin 2012-2026 | AMRX

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for AMNEAL PHARMACEUTICALS, INC (AMRX) over the last 10 years. The current EBITDA margin for AMNEAL PHARMACEUTICALS, INC as of June 30, 2026 is .
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
AMNEAL PHARMACEUTICALS, INC EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2026-06-30 $3.12B $0.67B 21.33%
2026-03-31 $3.05B $0.66B 21.69%
2025-12-31 $3.02B $0.64B 21.17%
2025-09-30 $2.94B $0.62B 21.22%
2025-06-30 $2.85B $0.65B 22.78%
2025-03-31 $2.83B $0.63B 22.26%
2024-12-31 $2.79B $0.52B 18.43%
2024-09-30 $2.68B $0.44B 16.49%
2024-06-30 $2.60B $0.42B 16.20%
2024-03-31 $2.50B $0.40B 16.15%
2023-12-31 $2.39B $0.45B 18.63%
2023-09-30 $2.39B $0.47B 19.65%
2023-06-30 $2.31B $0.44B 19.11%
2023-03-31 $2.27B $0.17B 7.26%
2022-12-31 $2.21B $0.15B 6.91%
2022-09-30 $2.14B $0.13B 6.03%
2022-06-30 $2.12B $0.11B 5.28%
2022-03-31 $2.10B $0.38B 17.87%
2021-12-31 $2.09B $0.40B 18.91%
2021-09-30 $2.07B $0.40B 19.50%
2021-06-30 $2.06B $0.38B 18.28%
2021-03-31 $1.99B $0.32B 16.16%
2020-12-31 $1.99B $0.34B 16.81%
2020-09-30 $1.88B $0.29B 15.21%
2020-06-30 $1.74B $0.17B 9.49%
2020-03-31 $1.68B $0.13B 7.56%
2019-12-31 $1.63B $0.00B 0.12%
2019-09-30 $1.73B $0.05B 3.01%
2019-06-30 $1.83B $0.23B 12.49%
2019-03-31 $1.83B $0.05B 2.56%
2018-12-31 $1.66B $0.13B 8.00%
2018-09-30 $1.50B $0.24B 15.80%
2018-06-30 $1.28B $0.21B 16.42%
2018-03-31 $1.13B $0.40B 35.56%
2017-12-31 $1.03B $0.30B 28.53%
2017-09-30 $1.09B $0.60B 54.63%
2017-06-30 $1.06B $0.26B 24.25%
2017-03-31 $0.98B $0.24B 24.67%
2016-12-31 $1.02B $0.32B 31.50%
2016-09-30 $0.91B $-0.12B -12.76%
2016-06-30 $0.90B $0.18B 19.51%
2016-03-31 $0.94B $0.19B 19.94%
2015-12-31 $0.86B $0.14B 16.05%
2015-09-30 $0.71B $0.10B 13.82%
2015-06-30 $0.65B $0.09B 13.31%
2015-03-31 $0.62B $0.11B 17.90%
2014-12-31 $0.60B $0.12B 20.64%
2014-09-30 $0.57B $0.10B 17.84%
2014-06-30 $0.54B $0.07B 13.49%
2014-03-31 $0.48B $0.03B 6.00%
2013-12-31 $0.51B $0.03B 5.86%
2013-09-30 $0.55B $0.11B 19.75%
2013-06-30 $0.57B $0.14B 23.89%
2013-03-31 $0.60B $0.17B 27.62%
2012-12-31 $0.58B $0.17B 29.55%
2012-09-30 $0.60B $0.14B 24.00%
2012-06-30 $0.57B $0.14B 24.56%
2012-03-31 $0.53B $0.12B 21.72%
2011-12-31 $0.51B $0.12B 23.15%
2011-09-30 $0.45B $0.09B 20.70%
2011-06-30 $0.64B $0.29B 45.30%
2011-03-31 $0.67B $0.32B 48.57%
2010-12-31 $0.88B $0.52B 58.59%
2010-09-30 $0.96B $0.55B 57.53%
2010-06-30 $0.72B $0.36B 49.51%
2010-03-31 $0.62B $0.31B 49.84%
2009-12-31 $0.36B $0.11B 29.61%
2009-09-30 $0.23B $0.06B 25.55%
2009-06-30 $0.20B $0.02B 11.06%
2009-03-31 $0.22B $0.05B 23.64%
2008-12-31 $0.21B $0.05B 25.59%
2008-09-30 $0.20B $0.05B 27.41%
2008-06-30 $0.19B $0.06B 32.98%
2008-03-31 $0.15B $0.03B 20.53%
2004-09-30 $0.12B $0.01B 9.32%
2004-06-30 $0.10B $0.01B 5.83%
2004-03-31 $0.09B $0.00B 3.49%
2003-12-31 $0.06B $-0.01B -17.24%
2003-09-30 $0.05B $-0.01B -20.41%
2003-06-30 $0.04B $-0.01B -26.83%
2003-03-31 $0.03B $-0.02B -46.88%
2002-12-31 $0.02B $-0.02B -75.00%
2002-09-30 $0.02B $-0.02B -111.11%
2002-06-30 $0.01B $-0.02B -175.00%
2002-03-31 $0.01B $-0.02B -262.50%
2001-12-31 $0.01B $-0.02B -285.71%
2001-09-30 $0.01B $-0.02B -350.00%
2001-06-30 $0.01B $-0.02B -271.43%
2001-03-31 $0.01B $-0.02B -200.00%
2000-12-31 $0.01B $-0.02B -160.00%
2000-09-30 $0.01B $-0.01B -80.00%
2000-06-30 $0.01B $-0.01B -50.00%
2000-03-31 $0.01B $0.00B -22.22%
1999-12-31 $0.01B $0.00B -12.50%
1999-09-30 $0.01B $0.00B -37.50%
1999-06-30 $0.01B $0.00B -66.67%
1999-03-31 $0.01B $0.00B -80.00%
1998-12-31 $0.00B $0.00B -100.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $5.317B $3.019B
Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories Inc., is based in New Jersey, United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $68.396B 22.59
Takeda Pharmaceutical (TAK) Japan $59.919B 11.13
UCB SA (UCBJY) Belgium $45.739B 0.00
Otsuka Holdings, - (OTSKY) Japan $39.680B 14.84
BeOne Medicines - (ONC) Switzerland $38.041B 61.00
Sandoz Group AG (SDZNY) Switzerland $35.464B 0.00
Daiichi Sankyo, - (DSNKY) Japan $34.072B 21.27
Zoetis (ZTS) United States $30.343B 11.16
Astellas Pharma (ALPMY) Japan $26.892B 8.90
United Therapeutics (UTHR) United States $21.460B 17.90
Merck (MKKGY) Germany $19.487B 15.54
Shionogi (SGIOY) Japan $15.947B 9.37
IPSEN (IPSEY) France $15.395B 0.00
Neurocrine Biosciences (NBIX) United States $15.249B 20.72
Summit Therapeutics (SMMT) United States $13.881B 0.00
Orion OYJ (ORINY) Finland $12.984B 18.93
Madrigal Pharmaceuticals (MDGL) United States $12.089B 0.00
Corcept Therapeutics (CORT) United States $11.979B 263.86
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.965B 15.26
Crinetics Pharmaceuticals (CRNX) United States $9.013B 0.00
Eisai (ESAIY) $8.924B 0.00
Ionis Pharmaceuticals (IONS) United States $7.852B 0.00
Ono Pharmaceutical (OPHLF) Japan $7.049B 13.27
Stevanato Group S.p.A (STVN) Italy $6.523B 32.64
Centessa Pharmaceuticals (CNTA) United Kingdom $6.267B 0.00
Oruka Therapeutics (ORKA) United States $6.105B 0.00
Grifols, S.A (GRFS) Spain $5.009B 0.00
Definium Therapeutics (DFTX) United States $4.947B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.923B 0.00
Relay Therapeutics (RLAY) United States $4.157B 0.00
Indivior Pharmaceuticals (INDV) United States $4.039B 9.38
Enliven Therapeutics (ELVN) United States $3.910B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.855B 11.93
Amylyx Pharmaceuticals (AMLX) United States $3.694B 0.00
Dyne Therapeutics (DYN) United States $3.343B 0.00
Hypermarcas (HYPMY) Brazil $3.203B 9.10
Soleno Therapeutics (SLNO) United States $2.717B 228.83
NewAmsterdam Pharma (NAMS) Netherlands $2.529B 0.00
Guardian Pharmacy Services (GRDN) United States $2.390B 45.28
Nektar Therapeutics (NKTR) United States $2.275B 0.00
Ocular Therapeutix (OCUL) United States $2.238B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.146B 15.81
Avadel Pharmaceuticals (AVDL) Ireland $2.113B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.085B 5.63
Xencor (XNCR) United States $1.766B 0.00
KARDIGAN INC (KARD) United States $1.735B 0.00
Xeris Biopharma Holdings (XERS) United States $1.366B 107.00
Harrow (HROW) United States $1.269B 0.00
Seaport Therapeutics (SPTX) United States $1.229B 0.00
Aktis Oncology (AKTS) United States $1.204B 0.00
Cronos Group (CRON) Canada $1.179B 29.09
Bioventus (BVS) United States $1.093B 17.10
Savara (SVRA) United States $1.081B 0.00
KalVista Pharmaceuticals (KALV) United States $0.993B 0.00
Cybin (HELP) Canada $0.992B 0.00
Theravance Biopharma (TBPH) United States $0.885B 0.00
Avalo Therapeutics (AVTX) United States $0.862B 0.00
Ardelyx (ARDX) United States $0.847B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.821B 11.32
Esperion Therapeutics (ESPR) United States $0.819B 0.00
Aclaris Therapeutics (ACRS) United States $0.773B 0.00
Achieve Life Sciences (ACHV) Canada $0.753B 0.00
4D Molecular Therapeutics (FDMT) United States $0.753B 0.00
Silence Therapeutics (SLN) United Kingdom $0.750B 0.00
Apnimed (APMD) $0.711B 0.00
Collegium Pharmaceutical (COLL) United States $0.711B 3.13
Zevra Therapeutics (ZVRA) United States $0.692B 7.37
Ironwood Pharmaceuticals (IRWD) United States $0.671B 5.21
OmniAb (OABI) United States $0.630B 0.00
Altimmune (ALT) United States $0.628B 0.00
Aquestive Therapeutics (AQST) United States $0.604B 0.00
Evotec AG (EVO) Germany $0.580B 0.00
ProKidney (PROK) United States $0.526B 0.00
Indaptus Therapeutics (INDP) United States $0.485B 0.00
Relmada Therapeutics (RLMD) United States $0.474B 0.00
ARS Pharmaceuticals (SPRY) United States $0.423B 0.00
Larimar Therapeutics (LRMR) United States $0.406B 0.00
Prelude Therapeutics (PRLD) United States $0.361B 0.00
Century Therapeutics (IPSC) United States $0.359B 0.00
Lexeo Therapeutics (LXEO) United States $0.339B 0.00
Inhibikase Therapeutics (IKT) United States $0.322B 0.00
Avita Medical (RCEL) United States $0.314B 0.00
Pyxis Oncology (PYXS) United States $0.278B 0.00
USANA Health Sciences (USNA) United States $0.275B 15.05
Elite Pharmaceuticals (ELTP) United States $0.268B 12.44
Lyell Immunopharma (LYEL) United States $0.267B 0.00
Akebia Therapeutics (AKBA) United States $0.250B 0.00
Galectin Therapeutics (GALT) United States $0.246B 0.00
Nature's Sunshine Products (NATR) United States $0.230B 11.17
AleAnna (ANNA) United States $0.226B 17.84
Protara Therapeutics (TARA) United States $0.222B 0.00
Cardiol Therapeutics (CRDL) Canada $0.215B 0.00
Siga Technologies (SIGA) United States $0.214B 0.00
Journey Medical (DERM) United States $0.208B 0.00
Profound Medical (PROF) Canada $0.208B 0.00
Korro Bio (KRRO) United States $0.207B 0.00
Surrozen (SRZN) United States $0.206B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.199B 0.00
Organogenesis (ORGO) United States $0.188B 0.00
Minerva Neurosciences (NERV) United States $0.183B 0.00
MediWound (MDWD) Israel $0.173B 0.00
Atrium Therapeutics (RNA) United States $0.173B 0.00
NRx Pharmaceuticals (NRXP) United States $0.147B 0.00
Innate Pharma SA (IPHYF) France $0.138B 0.00
Unicycive Therapeutics (UNCY) United States $0.131B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.129B 0.00
VAXART, INC (VXRT) United States $0.117B 3.00
Assertio Holdings (ASRT) United States $0.116B 0.00
Rafael Holdings (RFL) United States $0.111B 0.00
Vivani Medical (VANI) United States $0.111B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.103B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.099B 0.00
PolyPid (PYPD) Israel $0.098B 0.00
HST Global (HSTC) United States $0.092B 0.00
ElectroCore (ECOR) United States $0.091B 0.00
Fractyl Health (GUTS) United States $0.090B 0.00
Nutriband (NTRB) United States $0.083B 0.00
Aldeyra Therapeutics (ALDX) United States $0.083B 0.00
Telomir Pharmaceuticals (TELO) United States $0.080B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.079B 0.00
Acrivon Therapeutics (ACRV) United States $0.078B 0.00
Gain Therapeutics (GANX) United States $0.075B 0.00
PMV Pharmaceuticals (PMVP) United States $0.073B 0.00
Champions Oncology (CSBR) United States $0.066B 0.00
Talphera (TLPH) United States $0.062B 0.00
Nuo Therapeutics (AURX) $0.061B 0.00
Heron Therapeutics (HRTX) United States $0.060B 0.00
Dominari Holdings (DOMH) United States $0.053B 0.00
Veraxa Biotech AG (VRXA) United States $0.048B 0.00
SCYNEXIS (SCYX) United States $0.044B 0.00
Incannex Healthcare (IXHL) Australia $0.041B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Lite Strategy (LITS) United States $0.037B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Karyopharm Therapeutics (KPTI) United States $0.035B 0.00
Context Therapeutics (CNTX) United States $0.033B 0.00
Optimi Health (OPTH) Canada $0.029B 0.00
Cosmos Health (COSM) United States $0.028B 0.00
TransCode Therapeutics (RNAZ) United States $0.027B 0.00
Plus Therapeutics (PSTV) United States $0.027B 0.00
TherapeuticsMD (TXMD) United States $0.025B 0.00
Universe Pharmaceuticals INC (UPC) China $0.022B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Klotho Neurosciences (KLTO) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Enlivex (ENLV) Israel $0.015B 0.00
Citius Pharmaceuticals (CTXR) United States $0.015B 0.00
BioVie (BIVI) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.015B 0.00
Vyome Holdings (HIND) United States $0.014B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Tempest Therapeutics (TPST) United States $0.012B 0.00
Natural Alternatives (NAII) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
CASI Pharmaceuticals (CASI) China $0.010B 0.00
Xenetic Biosciences (XBIO) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Wellgistics Health (WGRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Inotiv (NOTV) United States $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.007B 0.00
Ernexa Therapeutics (ERNA) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.005B 0.00
Liminatus Pharma (LIMN) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Niki BioSolutions (NIKI) United Kingdom $0.004B 0.00
Nuvilex (PMCB) United States $0.004B 0.00
Addex Therapeutics (ADXN) Switzerland $0.004B 0.00
Galmed Pharmaceuticals (EOCN) Israel $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Jupiter Neurosciences (JUNS) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Vivos Therapeutics (VVOS) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Clearmind Medicine (CMND) Canada $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
CDT Equity (CDT) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00